CoChat
Sign Up
Cited by 289Diabetes, Cardiovascular Risks, and LipoproteinsAdipokines, Inflammation, and Metabolic DiseasesCardiovascular Disease and Adiposity

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

Metabolic Effects of Visceral Fat Accumulation in Type 2 Diabetes

Gastaldelli, Amalia, Miyazaki, Yoshinori, Pettiti, Maura, Matsuda, Masafumi, Mahankali, Srihanth, Santini, Eleonora, DeFronzo, Ralph A., Ferrannini, Ele·2002·The Journal of Clinical Endocrinology & Metabolism
DOI 10.1210/jc.2002-020696
Open this paper in CoChat — free account

Abstract

Visceral fat (VF) excess has been associated with decreased peripheral insulin sensitivity and has been suggested to contribute to hepatic insulin resistance. However, the mechanisms by which VF impacts on hepatic glucose metabolism and the quantitative role of VF in glycemic control have not been investigated. In the present study 63 type 2 diabetic subjects (age, 55 +/- 1 yr; fasting plasma glucose, 5.5-14.4 mmol/liter; hemoglobin A(1c), 6.1-11.7%) underwent measurement of 1) fat-free mass ((3)H(2)O technique), 2) sc and visceral abdominal fat area (magnetic resonance imaging), 3) insulin sensitivity (euglycemic insulin clamp), 4) endogenous glucose output ([(3)H]glucose infusion technique), and 5) gluconeogenesis ((2)H(2)O method). After adjustment for sex, age, body mass index, diabetes duration, ethnicity, and sc fat area, VF area was positively related to fasting hyperglycemia (partial r = 0.46; P = 0.001) as well as to hemoglobin A(1c) (partial r = 0.50; P = 0.0003). Insulin sensitivity was reciprocally related to VF independently of body mass index (partial r = 0.33; P = 0.01). In contrast, the relation of basal endogenous glucose output to VF was not statistically significant. This lack of association was explained by the fact that VF was positively associated with gluconeogenesis flux (confounder-adjusted, partial r = 0.45; P = 0.003), but was reciprocally associated with glycogenolysis (partial r = 0.31; P < 0.05). We conclude that in patients with established type 2 diabetes, VF accumulation has a significant negative impact on glycemic control through a decrease in peripheral insulin sensitivity and an enhancement of gluconeogenesis.

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2002-020696

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 33 references

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Gastaldelli, A., Miyazaki, Y., Pettiti, M., Matsuda, M., Mahankali, S., Santini, E., DeFronzo, R. A., & Ferrannini, E.
Affiliations
  • University of Pisa (IT)
  • The University of Texas at San Antonio Health Science Center (US)
Corresponding author
Ferrannini, Ele
ORCID
Venue
The Journal of Clinical Endocrinology & Metabolism
Publisher
The Endocrine Society
Published
2002-11
Volume
87
Issue
11
Pages
5098-5103
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
DOI
10.1210/jc.2002-020696
OpenAlex
W1978270587
Cited by
289
References
33
Citations by year
2026: 6 · 2025: 16 · 2024: 10 · 2023: 18 · 2022: 14 · 2021: 13 · 2020: 11 · 2019: 19 · 2018: 7 · 2017: 6 · 2016: 15 · 2015: 11 · 2014: 12 · 2013: 19 · 2012: 12
FWCI
5.13
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
Funders
  • National Institute of Diabetes and Digestive and Kidney Diseases (DK 24092)
  • National Center for Research Resources (M01RR01346, M01RR001346)
  • NIH Clinical Center
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
Keywords
visceral fat, type 2 diabetes, insulin sensitivity, hepatic insulin resistance, gluconeogenesis, glycogenolysis, glycemic control, hyperglycemia, abdominal fat
MeSH terms
Adipose Tissue, Blood Glucose, Body Composition, Body Constitution, Deuterium, Diabetes Mellitus, Type 2, Fasting, Fatty Acids, Nonesterified, Female, Gluconeogenesis, Glucose, Glycated Hemoglobin, Humans, Hyperglycemia, Insulin Resistance, Liver, Magnetic Resonance Imaging, Male, Middle Aged, Regression Analysis, Tritium, Viscera, Glucose Clamp Technique, Body Mass Index

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review